Is this you? Create Your Porfile
Avatar

Mark Pickworth

University of Hertfordshire

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Mark Pickworth is active.

Explore More

Publication

Featured researches published by Mark Pickworth.

Archive | 2013

BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AGONISTS

Giles Albert Brown; Julie Elaine Cansfield; Miles Congreve; Mark Pickworth; Benjamin G. Tehan

Archive | 2018

ANTAGONISTAS DE RECEPTORES DE CGRP

Jonathan S. Mason; Mark Pickworth; Francesca Deflorian; Sarah Joanne Bucknell; Miles Congreve; John A. Christopher

F1000 - Post-publication peer review of the biomedical literature | 2018

Faculty of 1000 evaluation for Discovery of Potent 2-Aryl-6,7-dihydro-5 H-pyrrolo[1,2- a]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design.

Miles Congreve; Mark Pickworth

F1000 - Post-publication peer review of the biomedical literature | 2018

Faculty of 1000 evaluation for Mapping the efficiency and physicochemical trajectories of successful optimizations.

Miles Congreve; Mark Pickworth

F1000 - Post-publication peer review of the biomedical literature | 2018

Faculty of 1000 evaluation for Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2.

Miles Congreve; Mark Pickworth

F1000 - Post-publication peer review of the biomedical literature | 2018

Faculty of 1000 evaluation for Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond Donor.

Miles Congreve; Mark Pickworth

F1000 - Post-publication peer review of the biomedical literature | 2018

Faculty of 1000 evaluation for Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.

Miles Congreve; Mark Pickworth

F1000 - Post-publication peer review of the biomedical literature | 2018

Faculty of 1000 evaluation for Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria.

Miles Congreve; Mark Pickworth

Archive | 2017

compostos aza bicíclicos como agonistas de receptor m1 muscarínicos

Benjamin G. Tehan; Giles Albert Brown; Julie Elaine Cansfield; Mark Pickworth; Miles Congreve

Archive | 2017

MUSCARINIC RECEPTOR AGONISTS

Miles Congreve; Giles Albert Brown; Benjamin Gerald Tehan; Mark Pickworth; Julie Elaine Cansfield

Explore More

Collaboration

Dive into the Mark Pickworth's collaboration.

Top Co-Authors
Avatar

Giles Albert Brown

University of Hertfordshire

View shared research outputs
Top Co-Authors
Avatar

Julie Elaine Cansfield

University of Hertfordshire

View shared research outputs
Top Co-Authors
Avatar

Benjamin G. Tehan

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Benjamin Gerald Tehan

University of Hertfordshire

View shared research outputs
Top Co-Authors
Avatar

Miles Congreve

The Hertz Corporation

View shared research outputs
Top Co-Authors
Avatar

Barry John Teobold

University of Hertfordshire

View shared research outputs
Top Co-Authors
Avatar

Mark David Rackham

University of Hertfordshire

View shared research outputs
Top Co-Authors
Avatar

Michael Alistair O'brien

University of Hertfordshire

View shared research outputs
Top Co-Authors
Avatar

John A. Christopher

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Francesca Deflorian

National Institutes of Health

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge